There are some aspects of this fund which may require extra consideration before deciding to invest.
Restrictions on acquisition
In this case, there are limits or exclusions on buying this investment that are important to know and acknowledge before you do.
There is no general public offer. Members of the public wishing to subscribe for shares must be allocated shares by an NZX Firm; there is no public pool under which you can subscribe for shares. You should contact an NZX Firm to determine whether you may be offered shares under the Broker Firm Offer.
Issuer's description of this product:
Ordinary shares in AFT Pharmaceuticals Limited
Minimum investment
This is the minimum amount you would need to put into this in order to invest.
Fixed offer price
Closing date
This is when this offer closes to investors.
Key facts
Provider website
Intending to list
The issuer has indicated that they are intending to list this investment on a public exchange, or that it is already listed. See the listing here:
Issuer's industry
Healthcare/social assistance
Fixed offer price details
Key documents
These are the most important documents that a provider is required to file about this investment.
Product disclosure statement
Before you invest in a product like a fund, you are given a PDS which has essential details about it and the company providing it. Here's more on how to read a PDS.
AFT Pharmaceuticals Limited - Replacement PDS.pdf
How this investment works, including about the provider, risks, costs and potential returns
Additional disclosure documents
These are more documents from the provider that can contain interesting information.
Reconciliation of non-GAAP to GAAP information.pdf
Escrow deed - CRG.pdf
Escrow deed - Directors and senior manager.pdf
Escrow deed - Atkinson Family Trust.pdf
CRG loan agreement.pdf
Other material information relating to the Offer.pdf
Additional details
Issuer details
Name
AFT PHARMACEUTICALS LIMITED
Type
NZ Limited Company
Industry
Healthcare/social assistance
Website
NZBN
9429038010415
Credit rating
Not provided
Offer details
Date registered
26 November 2015
Date opened
04 December 2015
Closing date
17 December 2015
Continuous issue
No
Further payments may be required
No
Restrictions on transfer
No
Restrictions on acquisition
Yes: There is no general public offer. Members of the public wishing to subscribe for shares must be allocated shares by an NZX Firm; there is no public pool under which you can subscribe for shares. You should contact an NZX Firm to determine whether you may be offered shares under the Broker Firm Offer.
Convertible product
No
Intending to list
Yes
Schedule 1 exemption
No
FMA exemption
No
Reference numbers
Offer
OFR10331: INITIAL PUBLIC OFFERING OF ORDINARY SHARES IN AFT PHARMACEUTICALS LIMITED
Next steps
Want to know more about this investment or how it compares to others? Have a look at its peers.
Product disclosure statement
Take a deeper dive into the PDS, which has essential details about this offer and the company providing it. Here's more on how to read a PDS.
Market listing
The provider has indicated they are intending to list this investment, or that it is already listed, on a public securities market. Here's where to find the market listing:
Getting investment advice
Good advice is gold. Everyone can benefit from expert advice, provided the adviser has your interests at heart. Here's how to find one and key questions to ask.
Interested in investing in this offer? Visit the provider's website. aftpharm.com